英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字,中文词皆可:


请选择你想看的字典辞典:
单词字典翻译
845948查看 845948 在百度字典中的解释百度英翻中〔查看〕
845948查看 845948 在Google字典中的解释Google英翻中〔查看〕
845948查看 845948 在Yahoo字典中的解释Yahoo英翻中〔查看〕





安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Cynata Therapeutics
    The official website of Cynata Therapeutics Access real-time announcements, direct Q A with leadership, and all the latest company updates
  • Management team | Cynata Therapeutics
    The official website of Cynata Therapeutics Access real-time announcements, direct Q A with leadership, and all the latest company updates
  • Share Price | Cynata Therapeutics
    The official website of Cynata Therapeutics Access real-time announcements, direct Q A with leadership, and all the latest company updates
  • Intellectual Property | Cynata Therapeutics
    The official website of Cynata Therapeutics Access real-time announcements, direct Q A with leadership, and all the latest company updates
  • Announcements | Cynata Therapeutics
    The official website of Cynata Therapeutics Access real-time announcements, direct Q A with leadership, and all the latest company updates
  • Clinical Development | Cynata Therapeutics
    Clinical development Cynata is advancing a diverse pipeline of innovative stem cell therapies based on our proprietary Cymerus™ technology platform Our clinical-stage programs span multiple therapeutic areas with significant unmet medical needs, positioning us at the forefront of regenerative medicine
  • ASX:CYP - Annual Report to Shareholders - cynata. com
    Read and interact with this announcement: Annual Report to Shareholders on Cynata Therapeutics's investor hub
  • Scientific Publications | Cynata Therapeutics
    The official website of Cynata Therapeutics Access real-time announcements, direct Q A with leadership, and all the latest company updates
  • Euroz Hartleys: Worlds First iPSC-Based Drug Approved - cynata. com
    The report analyses how these regulatory milestones validate the iPSC technology underpinning Cynata's Cymerus™ platform and their implications for our development pathway as we approach dual Phase 2 and Phase 3 trial readouts in Q2 2026 Euroz Hartleys maintains Speculative Buy recommendation with A$0 90 price target
  • Financial Reports | Cynata Therapeutics
    The official website of Cynata Therapeutics Access real-time announcements, direct Q A with leadership, and all the latest company updates





中文字典-英文字典  2005-2009